Provectus
is a Tennessee-based clinical-stage biotechnology company that develops immunotherapy medicines to treat diseases in areas such as oncology and dermatology... Read moreProvectus
is a Tennessee-based clinical-stage biotechnology company that develops immunotherapy medicines to treat diseases in areas such as oncology and dermatology... Read more
News
May 04, 2026
Citybizlist
Provectus: Bascom Palmer Eye Institute Showcases Four ARVO 2026 Posters Highlighting Rose Bengal Therapy for Infectious Keratitis
Apr 20, 2026
Marketscreener
Provectus: Provectus Biopharmaceuticals to Hold 2026 Annual Meeting of Stockholders at Perkins Place, Its Planned New Headquarters in Knoxville, Tennessee
Apr 02, 2026
GlobalNewswire
Press Release: Provectus : Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment
Mar 27, 2026
Owler
Provectus Biopharmaceuticals, Inc.: Provectus's employee count had no change from Dec 2024 to Dec 2025
Mar 26, 2026
Yahoo
Provectus: Provectus: Q4 Earnings Snapshot
Nov 13, 2025
Yahoo
Provectus: Provectus: Q3 Earnings Snapshot
Oct 09, 2025
GlobalNewswire
Press Release: Provectus : Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
Sep 29, 2025
GlobalNewswire
Press Release: Provectus : Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
Jun 26, 2025
GlobalNewswire
Press Release: Provectus : Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer
Jun 09, 2025
GlobeNewswire
Press Release: Provectus : Provectus Biopharmaceuticals Announces Investor Webinar for 2025 Annual Meeting of Stockholders
Provectus Competitors
1
2
3
4
5
6
7
8
9
10